Cite
HARVARD Citation
Arad, N. et al. (2022). Overcoming Barriers to Biosimilar Adoption: Commentary on "Cost to Medicare of Delayed Adalimumab Biosimilar Availability". Clinical pharmacology & therapeutics. 112 (1), pp. 25-27. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Arad, N. et al. (2022). Overcoming Barriers to Biosimilar Adoption: Commentary on "Cost to Medicare of Delayed Adalimumab Biosimilar Availability". Clinical pharmacology & therapeutics. 112 (1), pp. 25-27. [Online].